Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Rui

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Journal of Medicinal Chemistry|November 7, 2016
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agentsMarta Rui, Daniela Rossi, Annamaria Marra, et al.
Frontiers in Pharmacology|June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic CancerAnna Tesei, Michela Cortesi, Sara Pignatta, et al.
European Journal of Medicinal Chemistry|September 18, 2018
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agentsMarta Rui, Giacomo Rossino, Stefania Coniglio, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|September 29, 2021
The epidemiology and management of ameloblastomas: A European multicenter studyPaolo Boffano, Francesco Cavarra, Gerardo Tricarico, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Journal of Medicinal Chemistry|November 7, 2016
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agentsMarta Rui, Daniela Rossi, Annamaria Marra, et al.
Frontiers in Pharmacology|June 4, 2019
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic CancerAnna Tesei, Michela Cortesi, Sara Pignatta, et al.
European Journal of Medicinal Chemistry|September 18, 2018
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agentsMarta Rui, Giacomo Rossino, Stefania Coniglio, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|September 29, 2021
The epidemiology and management of ameloblastomas: A European multicenter studyPaolo Boffano, Francesco Cavarra, Gerardo Tricarico, et al.
Pageof 3